S84.F SCOPE FLUIDICS SA ZY-10

Healthcare Biotechnology Frankfurt Exchange
31.86 EUR
Close of Nov 12, 2026
22.65 37.45
Market cap
EUR 101M
P/E
-
P/B
2.92x
ROE
-34.0%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is S84.F undervalued?

Graham number

The Graham number of SCOPE FLUIDICS SA ZY-10 cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

SCOPE FLUIDICS SA ZY-10 fundamental analysis

No fundamental analysis for SCOPE FLUIDICS SA ZY-10 yet.

SCOPE FLUIDICS SA ZY-10 stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About SCOPE FLUIDICS SA ZY-10

Scope Fluidics S.A., a biotechnology company, designs and develops projects based on microfluidic technologies in medical diagnostics and healthcare in Poland. It offers BacterOMIC, an antibiotic susceptibility testing. Scope Fluidics S.A. was founded in 2010 and is headquartered in Warsaw, Poland.

Full company profile